Acorn Capital Advisors, LLC Y M Abs Therapeutics, Inc. Transaction History
Acorn Capital Advisors, LLC
- $185 Billion
- Q4 2024
A detailed history of Acorn Capital Advisors, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 2,861,825 shares of YMAB stock, worth $17.9 Million. This represents 12.11% of its overall portfolio holdings.
Number of Shares
2,861,825Holding current value
$17.9 Million% of portfolio
12.11%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
112Shares Held
27.1MCall Options Held
40.3KPut Options Held
400-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$26.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$18.3 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$13.7 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$12.5 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$11.4 Million0.09% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $273M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...